Influence of epirubicin and epurox treatment on mouse peritoneal macrophages.
Daicoviciu
D
D
Rişcă
R
R
Crişan
M
M
Szegli
G
G
Papilian
C
C
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002374:Catalase / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D015251:Epirubicin / Q000494:pharmacology*; D005260:Female; D008262:Macrophage Activation / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D051379:Mice; D010529:Peritoneal Cavity / Q000166:cytology; D010587:Phagocytosis / Q000187:drug effects; D011961:Receptors, Fc / Q000187:drug effects; D012397:Rosette Formation; D013482:Superoxide Dismutase / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D011961:Receptors, Fc; D015251:Epirubicin; D002374:Catalase; D013482:Superoxide Dismutase; C050165:epurox